Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly
UBX Unity Biotechnology, Inc. daily Stock Chart
UBX [NASD]
Unity Biotechnology, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.89 Insider Own0.50% Shs Outstand47.53M Perf Week10.79%
Market Cap273.30M Forward P/E- EPS next Y-2.18 Insider Trans0.00% Shs Float38.53M Perf Month-7.70%
Income-82.20M PEG- EPS next Q-0.53 Inst Own76.70% Short Float12.69% Perf Quarter-20.69%
Sales- P/S- EPS this Y30.30% Inst Trans25.00% Short Ratio21.76 Perf Half Y-6.96%
Book/sh2.58 P/B2.23 EPS next Y0.00% ROA-54.10% Target Price21.40 Perf Year-29.27%
Cash/sh2.68 P/C2.14 EPS next 5Y- ROE-64.60% 52W Range4.62 - 10.41 Perf YTD-20.25%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-44.78% Beta-
Dividend %- Quick Ratio7.50 Sales past 5Y- Gross Margin- 52W Low24.46% ATR0.58
Employees98 Current Ratio7.50 Sales Q/Q- Oper. Margin- RSI (14)50.94 Volatility10.57% 10.40%
OptionableYes Debt/Eq0.00 EPS Q/Q26.50% Profit Margin- Rel Volume1.33 Prev Close5.74
ShortableYes LT Debt/Eq0.00 EarningsMar 11 AMC Payout- Avg Volume224.73K Price5.75
Recom2.00 SMA203.45% SMA50-6.84% SMA200-17.40% Volume297,866 Change0.17%
Dec-12-19Initiated Cantor Fitzgerald Overweight $20
Mar-07-19Initiated Cantor Fitzgerald Overweight $21
Sep-07-18Initiated Mizuho Buy
May-29-18Initiated Morgan Stanley Overweight $25
May-29-18Initiated Goldman Neutral $17
May-29-18Initiated Citigroup Buy $32
Mar-11-20 04:05PM  UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
Mar-03-20 04:05PM  UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire -5.99%
Mar-02-20 04:30PM  UNITY Biotechnology Appoints Anirvan Ghosh, Ph.D. as Chief Executive Officer GlobeNewswire
Feb-25-20 06:00AM  UNITY Biotechnology Provides Pipeline and Business Updates GlobeNewswire
Feb-24-20 04:05PM  UNITY Biotechnology, Inc. to Participate in the Cowen and Company 40th Annual Health Care Conference GlobeNewswire -6.09%
Jan-30-20 01:49PM  Did Changing Sentiment Drive Unity Biotechnology's (NASDAQ:UBX) Share Price Down By 45%? Simply Wall St.
Dec-22-19 05:09PM  Here is What Hedge Funds Think About Unity Biotechnology, Inc. (NUBX) Insider Monkey
Nov-06-19 04:05PM  UNITY Biotechnology, Inc. Reports Third Quarter 2019 Financial Results and Business Updates GlobeNewswire
Oct-31-19 02:14PM  Unity Biotechnology, Inc. (UBX) Is Burning These Hedge Funds Insider Monkey
08:00AM  UNITY Biotechnology, Inc. Announces First Patient Dosed in Phase 2 Study of UBX0101 in Osteoarthritis of the Knee GlobeNewswire
Oct-24-19 08:00AM  UNITY Biotechnology, Inc. Announces Upcoming Scientific Presentations at ACR 2019 Annual Meeting GlobeNewswire
Oct-23-19 03:29PM  We're Keeping An Eye On Unity Biotechnology's (NASDAQ:UBX) Cash Burn Rate Simply Wall St.
08:00AM  Unity Biotechnology, Inc. to Announce Third Quarter 2019 Financial Results GlobeNewswire
Sep-20-19 08:00AM  UNITY Biotechnology, Inc. to Participate in the 2019 Cantor Global Healthcare Conference GlobeNewswire
Aug-27-19 08:00AM  UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-23-19 12:50PM  Did You Manage To Avoid Unity Biotechnology's (NASDAQ:UBX) Painful 66% Share Price Drop? Simply Wall St.
Aug-22-19 10:09AM  Unity Biotech: Buy at the Low? Motley Fool
Aug-07-19 04:05PM  UNITY Biotechnology, Inc. Reports Second Quarter 2019 Financial Results and Program Updates GlobeNewswire
Jul-30-19 04:30PM  UNITY Biotechnology, Inc. Announces Plan for Phase 2 Clinical Study of UBX0101 in Osteoarthritis of the Knee GlobeNewswire +7.80%
08:00AM  UNITY Biotechnology, Inc. To Announce Second Quarter 2019 Financial Results GlobeNewswire
Jun-18-19 02:47PM  Here's Why Unity Biotechnology Dropped as Much as 20.4% Today Motley Fool -7.20%
07:00AM  UNITY Biotechnology Reports Promising Topline Data from Phase 1 First-in-human Study of UBX0101 in Patients with Osteoarthritis of the Knee GlobeNewswire
May-30-19 07:33AM  The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug Benzinga
May-29-19 04:05PM  UNITY Biotechnology, Inc. and UCSF Enter Exclusive License Agreement on alpha-Klotho Protein for the Treatment of Age-Related Cognitive Decline GlobeNewswire -6.01%
May-23-19 04:01PM  UNITY Biotechnology, Inc. to Present at Upcoming Investor Conferences GlobeNewswire -7.69%
09:19AM  The Zacks Analyst Blog Highlights: Cambrex, Innoviva, Celgene, BioDelivery Sciences International and Unity Biotechnology Zacks
May-22-19 07:21AM  5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon Zacks
May-11-19 10:43AM  Do Directors Own Unity Biotechnology, Inc. (NASDAQ:UBX) Shares? Simply Wall St.
May-08-19 04:05PM  UNITY Biotechnology, Inc. Reports First Quarter 2019 Financial Results GlobeNewswire
Apr-29-19 04:05PM  UNITY Biotechnology, Inc. to Announce First Quarter 2019 Financial Results GlobeNewswire
Mar-06-19 08:00AM  UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Program Updates GlobeNewswire -11.15%
Mar-04-19 04:05PM  UNITY Biotechnology, Inc. to Participate in the Cowen 39th Annual Health Care Conference GlobeNewswire
Feb-27-19 04:05PM  CORRECTING and REPLACING -- UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-25-19 04:05PM  UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Jan-23-19 07:22AM  The Daily Biotech Pulse: PTC Therapeutics, Select Biosciences Offering, Unity Biotech Expands Early-Stage Osteoarthritis Drug Study Benzinga
Jan-22-19 04:05PM  UNITY Biotechnology Expands Ongoing UBX0101 Phase 1 Study to Further Evaluate SASP Factors in Osteoarthritis of the Knee GlobeNewswire
Jan-08-19 07:00AM  Ascentage Pharma Announces New License with Unity Biotechnology PR Newswire
Jan-03-19 04:52PM  UNITY Biotechnology Announces Completion of UBX1967 License and Advance into IND-Enabling Studies for Age-Related Diseases of the Eye GlobeNewswire
Dec-05-18 10:35AM  This year's Bay Area IPO batch remains up 44% despite market turbulence American City Business Journals
08:46AM  UNITY (UBX) Soars: Stock Adds 5.1% in Session Zacks
Dec-04-18 08:00AM  UNITY Biotechnology, Inc. Appoints Margo Roberts Ph.D. to Board of Directors GlobeNewswire +5.05%
07:59AM  The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO Benzinga
Dec-03-18 05:30PM  UNITY Biotechnology Announces Additional Cohort to Evaluate Higher Dose in Ongoing UBX0101 Phase 1 Study in Osteoarthritis of the Knee GlobeNewswire +6.30%
Nov-13-18 08:00AM  UNITY Biotechnology, Inc. to Host Investor & Analyst Event on Cellular Senescence GlobeNewswire
Nov-07-18 04:05PM  UNITY Biotechnology, Inc. Reports Third Quarter 2018 Financial Results GlobeNewswire
Oct-31-18 04:05PM  UNITY Biotechnology, Inc. to Announce Third Quarter 2018 Financial Results GlobeNewswire
Oct-01-18 01:34PM  24 Bay Area companies have gone public so far this year. Here's how they've done. American City Business Journals
Sep-24-18 04:05PM  UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference GlobeNewswire
Sep-20-18 02:59PM  Do You Know Who Else Invests In Unity Biotechnology Inc (NASDAQ:UBX)? Simply Wall St.
Sep-17-18 08:00AM  Todays Research Reports on Stocks to Watch: Unity Biotechnology and Principia Biopharma ACCESSWIRE
Sep-14-18 09:53AM  Unity (UBX) Catches Eye: Stock Jumps 8.8% Zacks +10.00%
Sep-13-18 02:46PM  Unity Biotech CEO: We can 'absolutely' create drugs that slow, halt or reverse diseases of aging CNBC +8.81%
Sep-05-18 04:05PM  UNITY Biotechnology, Inc. to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference GlobeNewswire
Aug-29-18 09:39AM  Why Jeff Bezos is backing this Silicon Valley scientist who is working on a cure for aging CNBC
Aug-09-18 04:05PM  UNITY Biotechnology, Inc. Reports Second Quarter 2018 Financial Results GlobeNewswire
Jul-31-18 04:05PM  UNITY Biotechnology, Inc. to Announce Second Quarter 2018 Financial Results GlobeNewswire
Jul-13-18 02:45PM  Here are Q2's 10 biggest VC-backed exits from the Bay Area American City Business Journals
Jun-25-18 08:00AM  UNITY Biotechnology, Inc. Announces First Patient Treated in UBX0101 Phase 1 Trial for Osteoarthritis of the Knee GlobeNewswire
Jun-13-18 04:00PM  UNITY Biotechnology, Inc. Added to Russell 3000®, 2000® and MicroCap® Indexes GlobeNewswire
07:20AM  Wired News Alexion Pharma and Complement Pharma Inked Deal to Co-develop Preclinical C6 Complement Inhibitor CP010 ACCESSWIRE
Jun-07-18 05:00PM  UNITY Biotechnology, Inc. Reports First Quarter 2018 Financial Results GlobeNewswire
Jun-05-18 04:05PM  UNITY Biotechnology, Inc. to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference GlobeNewswire
10:00AM  A Biotech Entrepreneur Aims To Help Us Stay Young While Growing Old Forbes
May-29-18 04:05PM  UNITY Biotechnology, Inc. to Announce First Quarter 2018 Financial Results GlobeNewswire
04:04PM  Unity Biotech Is A Buy On 'Novel Biology,' Morgan Stanley Says In Positive Initiation Benzinga
May-14-18 04:05PM  UNITY Biotechnology, Inc. Appoints Camille Landis as Senior Vice President of Corporate Development GlobeNewswire
10:32AM  3 New Healthcare Stocks to Buy Right Now InvestorPlace
May-07-18 04:05PM  UNITY Biotechnology, Inc. Announces Closing of Initial Public Offering GlobeNewswire
May-04-18 12:45AM  [$$] ARCH-backed Unity Bio Ends Lower in IPO The Wall Street Journal
May-03-18 04:37PM  Unity Biotech Shares Open For Trade Benzinga
May-02-18 07:10PM  UNITY Biotechnology, Inc. Announces Pricing of Initial Public Offering of Common Stock GlobeNewswire
12:45PM  [$$] Longevity Startups Come of Age The Wall Street Journal
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to extend human health span. The company's lead drug candidates include UBX0101 that is in Phase 1 clinical study for musculoskeletal disease; and UBX1967 for ophthalmologic diseases. It is also developing programs in pulmonary disorders. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was founded in 2009 and is headquartered in Brisbane, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goeltz II Robert C.Chief Financial OfficerFeb 24Option Exercise3.4310,00034,300134,404Feb 26 05:48 PM
open in yahoo | open in reuters | open in google